4
Changes in Ownership
Xenon Pharmaceuticals Inc. Filed Acc 0001193125-26-009232
Options or other derivatives
- Chief Legal Officer acquired 95,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| DiFabio Andrea Chief Legal Officer | 2026-01-09 | Grant or award · Share Option (Right to Buy) | +80,000 | 80,000 | D: show line 1 in the form | ||
| DiFabio Andrea Chief Legal Officer | 2026-01-09 | Grant or award · Restricted Share Units | +15,000 | 15,000 | D: show line 2 in the form |
Loading xslF345X05/ownership.xml…